US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
KR940702451A
(ko)
|
1991-09-06 |
1994-08-20 |
고야 다다시 |
4-아미로(알킬)시클로헥산-1-카르복사미드 화합물 및 그 용도
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
EP0710283A4
(en)
|
1993-07-22 |
1997-07-02 |
Merck & Co Inc |
THE EXPRESSION OF HUMAN INTERLEUKIN-1-g (b) IN A TRANSGENIC ANIMAL
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
EP2258726A1
(en)
|
1995-06-14 |
2010-12-08 |
The Regents of the University of California |
High affinity human antibodies to c-erbB-2
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
CA2263425C
(en)
|
1996-08-12 |
2008-09-30 |
Yoshitomi Pharmaceutical Industries Ltd. |
Pharmaceutical agent containing rho kinase inhibitor
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
CA2288639A1
(en)
|
1997-05-07 |
1998-11-12 |
Pharma Mar, S.A. |
Aplidine as an l-type calcium channel enhancer
|
ATE394484T1
(de)
|
1997-06-13 |
2008-05-15 |
Ludwig Inst Cancer Res |
Smad 6 und dessen anwendungen
|
ES2229515T3
(es)
|
1997-07-01 |
2005-04-16 |
Warner-Lambert Company Llc |
Derivados 4-bromo o 4-yodo del acido fenilamino benzhidroxamico y su uso como inhibidores de la mek.
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
JP2002521025A
(ja)
|
1998-07-24 |
2002-07-16 |
ザ カーネギー インスチチューション オブ ワシントン |
増殖因子のTGF−βファミリーのメンバーを使用する、生殖系列幹細胞の維持および増殖のための方法。
|
GB9819912D0
(en)
|
1998-09-11 |
1998-11-04 |
Univ Edinburgh |
Propagation and/or derivation of embryonic stem cells
|
WO2000040235A2
(en)
|
1999-01-07 |
2000-07-13 |
Warner-Lambert Company |
Treatment of asthma with mek inhibitors
|
US6703420B1
(en)
|
1999-03-19 |
2004-03-09 |
Bristol-Myers Squibb Pharma Company |
Amino-thio-acrylonitriles as MEK inhibitors
|
AU5250400A
(en)
|
1999-06-18 |
2001-01-09 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
AU6865100A
(en)
|
1999-09-02 |
2001-04-10 |
Mitsubishi Pharma Corporation |
Osteogenesis promoting agents
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
CN1219753C
(zh)
|
2000-07-19 |
2005-09-21 |
沃尼尔·朗伯公司 |
4-碘苯氨基苯氧肟酸的氧合酯
|
HN2002000067A
(es)
|
2001-03-23 |
2003-10-24 |
Bayer Healthcare Llc |
Inhibidores de la rho - quinasa.
|
TWI336328B
(en)
|
2001-03-23 |
2011-01-21 |
Bayer Healthcare Llc |
Rho-kinase inhibitors
|
AU2002257420A1
(en)
|
2001-05-01 |
2002-11-11 |
National Research Council Of Canada |
A system for inducible expression in eukaryotic cells
|
WO2003027277A1
(fr)
|
2001-09-21 |
2003-04-03 |
Japan Science And Technology Corporation |
Procede de criblage de facteur de reprogrammation, facteur de reprogrammation crible au moyen de ce procede, procede d'utilisation du facteur de reprogrammation, procede de differenciation de cellules fusionnees non differenciees et procede de construction de cellules, de tissus et d'organes
|
PT1456380E
(pt)
|
2001-11-02 |
2012-07-23 |
Giuliani Int Ltd |
Inibidores smad7 para o tratamento de doenças do snc
|
CA2472619A1
(en)
|
2002-01-10 |
2003-07-24 |
Bayer Corporation |
Fused pyrimidine derivates as rho-kinase inhibitors
|
WO2003062227A1
(en)
|
2002-01-23 |
2003-07-31 |
Bayer Pharmaceuticals Corporation |
Rho-kinase inhibitors
|
US6924290B2
(en)
|
2002-01-23 |
2005-08-02 |
Bayer Pharmaceuticals Corporation |
Rho-kinase inhibitors
|
DE60301953T2
(de)
|
2002-03-05 |
2006-07-27 |
Artemis Pharmaceuticals Gmbh |
Durch inzucht erzeugte von embryonalen stammzellen abgeleitete mäuse
|
ES2549159T3
(es)
|
2002-03-13 |
2015-10-23 |
Array Biopharma, Inc. |
Derivados de bencimidazol N3-alquilados como inhibidores de MEK
|
AU2003220935A1
(en)
|
2002-04-03 |
2003-10-13 |
Sumitomo Pharmaceuticals Company, Limited. |
Benzamide derivatives
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
WO2004039796A1
(de)
|
2002-10-28 |
2004-05-13 |
Bayer Healthcare Ag |
Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
|
MXPA05003431A
(es)
|
2002-11-15 |
2005-07-05 |
Warner Lambert Co |
Quimioterapia de combinacion.
|
US7265138B2
(en)
|
2003-02-10 |
2007-09-04 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
US20050075276A1
(en)
|
2003-03-14 |
2005-04-07 |
Christopher Rudd |
Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
US20060222657A1
(en)
|
2003-06-20 |
2006-10-05 |
Dowdy Steven F |
Polypeptide transduction and fusogenic peptides
|
US7727762B2
(en)
|
2003-10-03 |
2010-06-01 |
Keiichi Fukuda |
Method of inducing the differentiation of stem cells into myocardial cells
|
EP1679308B1
(en)
|
2003-10-15 |
2013-07-24 |
Ube Industries, Ltd. |
Novel indazole derivative
|
KR20070030164A
(ko)
|
2003-10-16 |
2007-03-15 |
더 유니버시티 코트, 더 유니버시티 오브 에딘버러 |
Es 세포 자가 재생 및 계통 지정의 조절, 및 이를 위한배지
|
DK1689233T3
(da)
|
2003-11-19 |
2012-10-15 |
Array Biopharma Inc |
Bicykliske inhibitorer af MEK
|
AU2004291559B2
(en)
|
2003-11-19 |
2008-10-16 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
JP2007519754A
(ja)
|
2004-01-30 |
2007-07-19 |
スミスクライン ビーチャム コーポレーション |
化合物
|
CA2563508A1
(en)
|
2004-04-21 |
2005-11-17 |
The University Of Chicago |
Myosin light chain kinase inhibitors and methods of use
|
CA2576872C
(en)
|
2004-08-13 |
2013-11-12 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for self-renewal and differentiation in human embryonic stem cells
|
WO2006026473A2
(en)
|
2004-08-25 |
2006-03-09 |
University Of Georgia Research Foundation, Inc. |
METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS
|
WO2006088867A2
(en)
|
2005-02-15 |
2006-08-24 |
Medistem Laboratories, Incorporated |
Method for expansion of stem cells
|
ES2333182T3
(es)
|
2005-05-18 |
2010-02-17 |
Array Biopharma, Inc. |
Derivados de 4-(fenilamino)-6-oxo-1,6-dihidropiridazina-3-carboxamida como inhibidores de mek para el tratamiento de enfermedades hiperproliferativas.
|
AU2006275479B2
(en)
|
2005-08-01 |
2012-11-29 |
Nupotential, Inc. |
Production of reprogrammed cells with restored potential
|
CA2621161A1
(en)
|
2005-09-08 |
2007-03-15 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Methods for promoting stem cell proliferation and survival
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
EP2208786B1
(en)
|
2005-12-13 |
2018-08-01 |
Kyoto University |
Nuclear reprogramming factor
|
US20090227032A1
(en)
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
GB0601538D0
(en)
|
2006-01-26 |
2006-03-08 |
Univ Birmingham |
Epigenetic analysis
|
WO2007088651A1
(ja)
|
2006-02-01 |
2007-08-09 |
The University Of Tokyo |
TGF-βシグナル阻害剤と抗腫瘍剤の組み合せ使用
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
AU2007232393A1
(en)
|
2006-03-30 |
2007-10-11 |
The University Court Of The University Of Edinburgh |
Culture medium containing kinase inhibitors. and uses thereof
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
US20070259423A1
(en)
|
2006-05-02 |
2007-11-08 |
Jon Odorico |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
KR20090042779A
(ko)
|
2006-06-30 |
2009-04-30 |
쉐링 코포레이션 |
P53 활성을 증가시키는 치환된 피페리딘 및 이의 사용
|
PT2044056E
(pt)
|
2006-07-14 |
2012-12-05 |
Novartis Ag |
Derivados de pirimidina como inibidores de alk-5
|
US20080020014A1
(en)
|
2006-07-19 |
2008-01-24 |
Paul Consigny |
Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
|
CN101563449A
(zh)
|
2006-09-22 |
2009-10-21 |
理化学研究所 |
干细胞培养基及干细胞培养方法
|
JP2008099662A
(ja)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
幹細胞の培養方法
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
WO2008089351A1
(en)
|
2007-01-17 |
2008-07-24 |
Wisconsin Alumni Research Foundation |
Improved culture of stem cells
|
US20100172883A1
(en)
|
2007-01-19 |
2010-07-08 |
Bruneau Benoit Gaetan |
Methods of generating cardiomyocytes
|
CN103627671A
(zh)
|
2007-01-30 |
2014-03-12 |
佐治亚大学研究基金会 |
产生中内胚层细胞及多能游走细胞的方法与细胞群及用途
|
EP2132225A4
(en)
|
2007-02-27 |
2010-06-09 |
Procell Therapeutics Inc |
COMBINED USE OF NANOG AND OCT4 PERMEABLE TO CELLS TO INCREASE SELF-RENEWAL AND DELETE DIFFERENTIATION OF STEM CELLS
|
EP2131840B1
(en)
|
2007-03-07 |
2018-10-17 |
MEI Pharma, Inc. |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
EP2554661B2
(en)
|
2007-04-18 |
2018-02-21 |
Hadasit Medical Research Services & Development Limited |
Stem cell-derived retinal pigment epithelial cells
|
US7878210B2
(en)
|
2007-06-04 |
2011-02-01 |
Philip Morris Usa Inc. |
Cellulose acetate fiber modification
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
JP2008307007A
(ja)
*
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
DK2173863T3
(en)
|
2007-06-29 |
2019-01-21 |
Fujifilm Cellular Dynamics Inc |
Automated method and apparatus for embryonic stem cell culture
|
US20120282229A1
(en)
|
2007-08-01 |
2012-11-08 |
Christian Kannemeier |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
EP3078738B1
(en)
|
2007-08-31 |
2020-05-20 |
Whitehead Institute for Biomedical Research |
Wnt pathway stimulation in reprogramming somatic cells
|
KR101564044B1
(ko)
|
2007-10-31 |
2015-10-28 |
고쿠리츠 다이가쿠 호진 교토 다이가쿠 |
핵초기화 방법
|
US20110151447A1
(en)
|
2007-11-06 |
2011-06-23 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
|
JP4604076B2
(ja)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
燃料電池用電解質膜
|
WO2009073523A2
(en)
|
2007-11-29 |
2009-06-11 |
Children's Hospital Of Orange County |
De-differentiation of human cells
|
US20110190730A1
(en)
|
2007-11-30 |
2011-08-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving oct4 protein
|
EP2227241A1
(en)
|
2007-11-30 |
2010-09-15 |
Cytomatrix PTY LTD |
Methods of inducing pluripotency involving sox2 protein
|
JP2011516042A
(ja)
|
2008-03-17 |
2011-05-26 |
へルムホルツ・ツェントルム・ミュンヘン−ドイチェス・フォルシュングスツェントルム・ヒューア・ゲズントハイト・ウント・ウムヴェルト(ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング) |
部位特異的組み換えを用いて無ベクター誘導多能性幹(iPS)細胞を作製するベクターおよびその方法
|
CA2718904C
(en)
|
2008-03-17 |
2017-01-03 |
The Scripps Research Institute |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
CN101550406B
(zh)
*
|
2008-04-03 |
2016-02-10 |
北京大学 |
制备多潜能干细胞的方法,试剂盒及用途
|
JP5562231B2
(ja)
|
2008-07-30 |
2014-07-30 |
国立大学法人京都大学 |
効率的な人工多能性幹細胞の樹立方法
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
CA2742583C
(en)
|
2008-11-04 |
2022-09-27 |
Viacyte, Inc. |
Stem cell aggregate suspension compositions and methods for differentiation thereof
|
CA2745266C
(en)
|
2008-12-03 |
2018-04-10 |
Yue Xu |
Stem cell cultures
|
CN104130976A
(zh)
|
2008-12-17 |
2014-11-05 |
斯克里普斯研究所 |
干细胞的产生和保持
|
WO2010102267A2
(en)
|
2009-03-06 |
2010-09-10 |
Ipierian, Inc. |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
WO2010120785A2
(en)
|
2009-04-13 |
2010-10-21 |
The Regents Of The University Of California |
Methods and compositions for stem cell cultures
|
WO2010138750A2
(en)
|
2009-05-27 |
2010-12-02 |
The Salk Institute For Biological Studies |
Generation of genetically corrected disease-free induced pluripotent stem cells
|
US8524498B2
(en)
|
2009-05-29 |
2013-09-03 |
The General Hospital Corporation |
Methods and compositions for homologous recombination in human cells
|
US9005975B2
(en)
|
2009-05-29 |
2015-04-14 |
Kyoto University |
Method for selecting clone of induced pluripotent stem cells
|
KR101774206B1
(ko)
|
2009-08-07 |
2017-09-04 |
고쿠리츠 다이가쿠 호진 교토 다이가쿠 |
유도된 다능성 줄기 세포의 효율적인 확립 방법
|
CA3091210C
(en)
|
2009-10-16 |
2023-04-04 |
The Scripps Research Institute |
Induction of pluripotent cells
|
MX353245B
(es)
|
2009-10-31 |
2018-01-08 |
New World Laboratories Inc Star |
Metodos para reprogramar células y sus usos.
|
JP5898086B2
(ja)
|
2009-11-04 |
2016-04-06 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
化学物質を用いるエピソームリプログラミング
|
EP4166652A1
(en)
|
2009-11-12 |
2023-04-19 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
US9005967B2
(en)
|
2010-01-22 |
2015-04-14 |
Kyoto University |
Myc variants improve induced pluripotent stem cell generation efficiency
|
CA2789774C
(en)
*
|
2010-02-17 |
2024-01-23 |
Biotime Inc. |
Methods for telomere length and genomic dna quality control analysis in pluripotent stem cells
|
CA2791901C
(en)
|
2010-03-05 |
2018-01-02 |
Texas Heart Institute |
Ets2 and mesp1 generate cardiac progenitors from fibroblasts
|
CN105176930B
(zh)
|
2010-03-31 |
2021-05-04 |
斯克里普斯研究所 |
重编程细胞
|
JPWO2011158852A1
(ja)
|
2010-06-15 |
2013-08-19 |
国立大学法人 東京大学 |
誘導型多能性幹細胞の製造方法
|
EP2582794B2
(en)
|
2010-06-15 |
2024-04-24 |
FUJIFILM Cellular Dynamics, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
US20110306516A1
(en)
*
|
2010-06-15 |
2011-12-15 |
The New York Stem Cell Foundation |
Methods for producing induced pluripotent stem cells
|
CA2806858C
(en)
|
2010-08-04 |
2021-06-15 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized b cells
|
WO2012087965A2
(en)
|
2010-12-22 |
2012-06-28 |
Fate Therapauetics, Inc. |
Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
|
US9458131B2
(en)
|
2011-11-08 |
2016-10-04 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
CA2858069C
(en)
|
2011-12-08 |
2020-02-11 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
WO2013159103A1
(en)
|
2012-04-20 |
2013-10-24 |
Whitehead Institute For Biomedical Research |
Programming and reprogramming of cells
|
JP6164746B2
(ja)
|
2012-05-22 |
2017-07-19 |
国立大学法人 東京大学 |
抗原特異的t細胞の製造方法
|
US9166832B1
(en)
|
2013-10-04 |
2015-10-20 |
Altera Corporation |
Methods and apparatus for decision feedback equalization adaptation
|
PT3114214T
(pt)
*
|
2014-03-04 |
2024-01-03 |
Fate Therapeutics Inc |
Métodos de reprogramação melhorados e plataformas de cultura celular
|
SG11201803144WA
(en)
|
2015-11-04 |
2018-05-30 |
Fate Therapeutics Inc |
Genomic engineering of pluripotent cells
|